Editor: Atta-ur-Rahman

Frontiers in Clinical Drug Research – Diabetes and Obesity

Volume 2

eBook: US $79 Special Offer (PDF + Printed Copy): US $158
Printed Copy: US $119
Library License: US $316
ISSN: 2467-9607 (Print)
ISSN: 2352-3220 (Online)
ISBN: 978-1-68108-186-1 (Print)
ISBN: 978-1-68108-185-4 (Online)
Year of Publication: 2017
DOI: 10.2174/97816810818541160201

Introduction

Frontiers in Clinical Drug Research – Diabetes and Obesity is an eBook series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of two metabolic diseases – diabetes and obesity. The scope of the eBook series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs affecting endocrine and metabolic processes linked with diabetes and obesity. Reviews in this series also include research on specific receptor targets and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research – Diabetes and Obesity is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of diabetes and obesity research.

The second volume of this series features 7 reviews presenting updates on hormones and several classes of drugs:

  • - Osteocalcin action in glucose metabolism
  • - Sodium-glucose co-transporter 2 (SGLT2) inhibitors
  • - Glucagon-like peptide-1 (GLP-1) mimetics
  • - Dipeptidyl peptidase 4 (DPP-4) inhibitors
  • - New drugs in clinical trial and commercial phases

Preface

- Pp. i
Atta-ur-Rahman
Download Free

List of Contributors

- Pp. iii
Atta-ur-Rahman
Download Free

The Current, Emerging and Future Medications for Type 2 Diabetes and Obesity

- Pp. 3-49 (47)
Hidesuke Kaji

PDF Price: $30

View Abstract Purchase Chapter

Antidiabetic Drugs of Type 2 Diabetes and Obesity

- Pp. 50-59 (10)
Tatjana Ábel and Gabriella Lengyel

PDF Price: $30

View Abstract Purchase Chapter

Sodium-Glucose Co-Transport Inhibitors: A New Therapeutic Option for Type 2 Diabetes Mellitus

- Pp. 60-83 (24)
Athanasia K. Papazafiropoulou and Marina S. Kardara

PDF Price: $30

View Abstract Purchase Chapter

Osteocalcin Plays as an Endocrine Hormone in Glucose Metabolism

- Pp. 84-101 (18)
Ippei Kanazawa

PDF Price: $30

View Abstract Purchase Chapter

Emerging Therapeutic Agents for the Treatment of Type 2 Diabetes Mellitus

- Pp. 102-149 (48)
Shivaprasad Channabasappa and Krishnan M. Prasanna Kumar

PDF Price: $30

View Abstract Purchase Chapter

Advances in New Drugs for Diabetes Treatment: GLP-1 Mimetics and DPP-4 Inhibitors

- Pp. 150-188 (39)
Xianglan Sun, Yao Wang and Minglong Li

PDF Price: $30

View Abstract Purchase Chapter

New and Promising Drugs for Obesity

- Pp. 189-234 (46)
Natalia G. Vallianou, Angelos A. Evangelopoulos and Christos E. Kazazis

PDF Price: $30

View Abstract Purchase Chapter

Subject Index

- Pp. 235-243 (9)
Atta-ur-Rahman
Download Free

RELATED BOOKS

.Phytotherapy in the Management of Diabetes and Hypertension.
.Phytotherapy in the Management of Diabetes and Hypertension.
.Frontiers in Clinical Drug Research – Diabetes and Obesity.
.Understanding Obesity: From its Causes to Impact on Life.